Photo: Rami Manochakian/ASCO
Jun 7, 2023, 10:31
After TKI , adding Pembro to chemo DOES NOT improve OS – Rami Manochakian
NEGATIVE results of Keynote789 trial:
Platinum + Pem +/- Pembro for TKI-resistant EGFR mutant NSCLC
❌PFS HR 0.8, P=0.0122
mPFS: 5.6 vs 5.5 mths
❌OS HR 0.84, P=0.0362
mOS: 15.9 vs 14.7 mths
After TKI , adding Pembro to chemo DOES NOT improve OS
Source: Rami Manochakian / Twitter
